PharmcoGen logo hosted by
Main
The Host
The E-Symposium
The Panel
Speakers and Program
Sponsorship
Sponsors
TEK-Centre
Pharmacogenomics E-Symposium

Platinum Sponsor

Gold Sponsor

Silver Sponsor
Free Registration

TEK-Centre




Applied Biosystems

» providing the world's leading technology and information solutions


DNAPrint

» Pharmacogenomic Tests


Gene Logic Inc.

» Your partner in drug development


GlaxoSmithKline

» Genetics


Tecan

» SNP Genotyping


Whatman plc

» Separations Technology








The brain expression of genes involved in inflammatory response, the ribosome, and learning and memory is altered by centrally injected lipopolysaccharide in mice


The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction


Nicotine abstinence genotyping: assessing the impact on smoking cessation clinical trials


Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy


Global meta-analysis of the C-11377G alteration in the ADIPOQ gene indicates the presence of population-specific effects: challenge for global health initiatives


Personalized medicine: are we there yet?


Designing pharmacogenetic projects in industry: practical design perspectives from the Industry Pharmacogenomics Working Group


Genome-wide approaches to identify pharmacogenetic contributions to adverse drug reactions


Prediction of CYP3A4 enzyme activity using haplotype tag SNPs in African Americans


DRD4 48?bp VNTR but not 5-HT2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain







Tecan and Promega co-develop large volume genomic DNA purification system
.pdf (98 KB)


Guidance for Industry Pharmacogenomic Data Submissions from the FDA, DHH, CDER, CBER & CDRH
.pdf (98 KB)


The Pharmacogenomics Journal
(2005) 5

.pdf (29 KB)

Contact Us Terms Login Demo FAQ Presentation Archive Sponsorship Booking Main

© 2005 e-symposium Ltd All Rights Reserved